Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > CCTEC celebrates banner year in 2009-10

Cornell Center for Technology, Enterprise and Commercialization (CCTEC)
Cornell Center for Technology, Enterprise and Commercialization (CCTEC)

Abstract:
With its highest-ever gross revenues and largest number of spinoff businesses launched to date, the Cornell Center for Technology, Enterprise and Commercialization (CCTEC) had its most successful year in fiscal year (FY) 2010.

By Anne Ju

CCTEC celebrates banner year in 2009-10

Ithaca, NY | Posted on December 9th, 2010

In the fiscal year that ended June 30, CCTEC granted 114 commercial licenses to industry partners to develop Cornell technologies. Also, 12 new businesses were founded on licensed Cornell technologies this year -- the highest number of startups spun out of Cornell in any fiscal year. The center grossed ordinary licensing revenues of $9 million this year, up from $5.1 million the previous year.

"CCTEC helps to make the results of the tremendous research at Cornell useful to the society and serve the public," said Alan Paau, Cornell's vice provost for technology transfer and economic development and executive director of CCTEC. "It bridges the academic-industry interface. To the extent possible, CCTEC leverages Cornell technologies to enhance regional economic vitality."

Of the 12 startups that CCTEC helped found this year, 11 are located in New York state. iFyber LLC, for example, is built on technology developed by Juan Hinestroza, assistant professor fiber science and apparel design. The company makes synthetic fibers functionalized with such properties as electrical conductivity, anti-microbial action and identity authentication using nanoparticle coatings.

Another startup, New York City-based Ezra Pharmaceutical, commercializes the work of Randi Silver, associate professor of physiology, and Roberto Levi, professor of pharmacology, both at Weill Cornell Medical College. The company is developing a first-ever preventative therapy for diabetes-related blindness, or diabetic retinopathy.

The center, whose mission is to develop Cornell science and technology into products and services for the public good, also kept pace with previous milestone numbers of new technology disclosures. FY 2009 was the first time that more than 300 new disclosures were made to CCTEC; in FY 2010 CCTEC again received more than 300 new disclosures.

Laura Cima, CCTEC's outreach and economic development manager, said CCTEC's mission aligns closely with Cornell's land-grant mission to serve the state and the wider public.

"Technology transfer is increasingly active at Cornell," Cima said. "It's good for New York state, good for Cornell and good for Cornell research."

In addition to its successes in commercialization and licensing, in 2010 CCTEC also settled two longstanding legal disputes related to Cornell inventions and licensing with industry partners, resulting in extraordinary revenues. Its ordinary licensing revenues were still the highest ever, even without the income from the legal settlements.

####

For more information, please click here

Contacts:
Media Contact:
Blaine Friedlander
(607) 254-8093


Cornell Chronicle:
Anne Ju
(607) 255-9735

Copyright © Cornell University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Jobs

Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022

SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020

March 17th, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019

Academic/Education

Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

National Space Society Helps Fund Expanding Frontier’s Brownsville Summer Entrepreneur Academy: National Space Society and Club for the Future to Support Youth Development Program in South Texas June 24th, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Textiles/Clothing

This new fabric coating could drastically reduce microplastic pollution from washing clothes: University of Toronto Engineering researchers are working on a fabric finish to prevent microplastic fibres from shedding during laundry cycles January 27th, 2023

Protective equipment with graphene nanotubes meets the strictest ESD safety standards March 25th, 2022

Polymer fibers with graphene nanotubes make it possible to heat hard-to-reach, complex-shaped items February 11th, 2022

Flexible material shows potential for use in fabrics to heat, cool July 3rd, 2020

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project